EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A novel peptide–drug conjugate GV-K for anti-colorectal cancer therapy via mitochondrial apoptosis

Lifeng Yu, Ying He, Guojia Liu, Qian Wei, Ruili Wang, Tongjie Wen, Jingqiu Chen, Qing Gao, Weitao Wang, Hualin Bai, Yan Wang, Chen Fu und 3 weitere

Acta Pharmaceutica Sinica B · 2026-11 · 16 (11) · 7448-7469

DOI: 10.1016/j.apsb.2026.06.055 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Pharmaceutica Sinica B, 2026-11. Verfasst von Lifeng Yu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang 110122, China. Die Arbeit nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: University of Science and Technology Liaoning, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

ANXA2 proteinColorectal cancerMitochondrial apoptotic pathwayPeptide–drug conjugatesPro-apoptotic peptideReceptor-mediated endocytosisTargeted therapyTumor homing peptide

Autor:innen und Institutionen

  • Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang 110122, China.
  • Liaoning Cancer Immune Peptide Drug Engineering Technology Research Center, China Medical University, Shenyang 110122, China.
  • Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, China Medical University, Shenyang 110122, China.
  • The First Department of Medical Oncology, Fourth Affiliated Hospital, China Medical University, Shenyang 110084, China.
  • Liaoning Medical Diagnosis and Treatment Center, Shenyang 110167, China.

Förderung

  • University of Science and Technology Liaoning
  • National Natural Science Foundation of China

Zitieren

APA

Yu, L., He, Y., Liu, G., Wei, Q., Wang, R., Wen, T., Chen, J., Gao, Q., Wang, W., Bai, H., Wang, Y., Fu, C., Yu, Z., Zhao, L., & Wei, M. (2026). A novel peptide–drug conjugate GV-K for anti-colorectal cancer therapy via mitochondrial apoptosis. Acta Pharmaceutica Sinica B, 16(11), 7448-7469. https://doi.org/10.1016/j.apsb.2026.06.055

Vancouver

Yu L, He Y, Liu G, Wei Q, Wang R, Wen T, et al. A novel peptide–drug conjugate GV-K for anti-colorectal cancer therapy via mitochondrial apoptosis. Acta Pharmaceutica Sinica B. 2026;16(11):7448-7469. doi:10.1016/j.apsb.2026.06.055

BibTeX
@article{Yu2026,
  author = {Yu, Lifeng and He, Ying and Liu, Guojia and Wei, Qian and Wang, Ruili and Wen, Tongjie and Chen, Jingqiu and Gao, Qing and Wang, Weitao and Bai, Hualin and Wang, Yan and Fu, Chen and Yu, Zhaojin and Zhao, Lin and Wei, Minjie},
  title = {A novel peptide–drug conjugate GV-K for anti-colorectal cancer therapy via mitochondrial apoptosis},
  journal = {Acta Pharmaceutica Sinica B},
  year = {2026},
  volume = {16},
  number = {11},
  pages = {7448--7469},
  doi = {10.1016/j.apsb.2026.06.055}
}
Kostenlos starten →